Oncology

Latest News

Data from the phase 3 3475A-D77 trial support the FDA approval of subcutaneous pembrolizumab across different pediatric and adult solid tumor indications.
FDA Approves SC Pembrolizumab Formulation in Solid Tumors

September 19th 2025

Data from the phase 3 3475A-D77 trial support the FDA approval of subcutaneous pembrolizumab across different pediatric and adult solid tumor indications.

Greater regulatory and policy clarity may better optimize clinician use of artificial intelligence in treating patients with cancer.
Advancing AI in Oncology: Critical Considerations for Clinical Practice

September 19th 2025

An independent data monitoring committee recommended the continuation of the phase 2 AMPLIFY-7P trial evaluating ELI-002 7P in PDAC in August 2025.
ELI-002 7P Elicits T Cell Responses in Mutant KRAS-Driven Tumors

September 18th 2025

Clinical benefit with the investigational agent was reported among 48% of patients with solid tumors at or above the therapeutic dose threshold.
LP-184 Shows Favorable Safety, Pharmacokinetics in Advanced Solid Tumors

September 17th 2025

Rezatapopt Yields Responses Across TP53 Y220C-Mutated Solid Tumor Types
Rezatapopt Yields Responses Across TP53 Y220C-Mutated Solid Tumor Types

September 10th 2025

Video Series
Video Interviews
Podcasts
Geraldine O’Sullivan Coyne, MD, MRCPI, PhD, discusses how the START center may expand access to novel therapies for patients who reside in a community.
Professor of Pharmacology, Eric Winer, MD, spoke about a publication he authored exploring the state of oncologist burnout and how it impacts practice.
Experts in gynecologic cancer, genitourinary malignancies, and other disciplines highlight noteworthy clinical data slated for presentation at ASCO 2025.
Authors of a manuscript published in ONCOLOGY® discuss how artificial intelligence may help with cancer detection and improving various patient outcomes.
Experts from Sibley Memorial Hospital discuss how multidisciplinary work has enhanced outcomes such as survival and resource use at their institution.
Latest CME Events & Activities

More News